Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Furst

Showing results (421-430 of 755) with videos related to

Pageof 76
Sort By:
Arthritis and Rheumatism|July 20, 2011
A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung diseaseDinesh Khanna, Rajeev Saggar, Maureen D Mayes, et al.
Arthritis and Rheumatism|September 29, 2011
Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendationsLeslie R Harrold, J Timothy Harrington, Jeffrey R Curtis, et al.
Annals of the Rheumatic Diseases|October 25, 2018
Imaging and serum biomarkers in connective tissue disease-associated interstitial lung diseases: correlation between lung ultrasound B-lines and KL-6 levelsYukai Wang, Shaoqi Chen, Zhangzhang Lin, et al.
The Journal of Rheumatology|February 17, 2007
Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosisVanessa L Malcarne, Ingunn Hansdottir, Ann McKinney, et al.
Arthritis and Rheumatism|March 31, 2007
Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohortDinesh Khanna, MyungShin Oh, Daniel E Furst, et al.
Clinical and Experimental Rheumatology|December 4, 2013
Recognition of pulmonary hypertension in the rheumatology community: lessons from a Quality Enhancement Research InitiativeD Khanna, Ma Tan, D E Furst, et al.
Lupus|June 24, 2022
Predictive model of risk and severity of enteritis in systemic lupus erythematosusWeijin Zhang, Guohai Huang, Jianqun Lin, et al.
Arthritis and Rheumatism|February 1, 1987
A controlled study of concurrent therapy with a nonacetylated salicylate and naproxen in rheumatoid arthritisD E Furst, K Blocka, S Cassell, et al.
The Journal of Rheumatology|February 11, 1998
Flare during drug withdrawal as a method to support efficacy in rheumatoid arthritis: amiprilose hydrochloride as an example in a double blind, randomized studyJ R Caldwell, D E Furst, A L Smith, et al.
Arthritis and Rheumatism|March 1, 1994
Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of RheumatologyJ M Kremer, G S Alarcón, R W Lightfoot, et al.
Pageof 76

Showing results (421-430 of 755) with videos related to

Sort By:
Pageof 76
Arthritis and Rheumatism|July 20, 2011
A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung diseaseDinesh Khanna, Rajeev Saggar, Maureen D Mayes, et al.
Arthritis and Rheumatism|September 29, 2011
Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendationsLeslie R Harrold, J Timothy Harrington, Jeffrey R Curtis, et al.
Annals of the Rheumatic Diseases|October 25, 2018
Imaging and serum biomarkers in connective tissue disease-associated interstitial lung diseases: correlation between lung ultrasound B-lines and KL-6 levelsYukai Wang, Shaoqi Chen, Zhangzhang Lin, et al.
The Journal of Rheumatology|February 17, 2007
Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosisVanessa L Malcarne, Ingunn Hansdottir, Ann McKinney, et al.
Arthritis and Rheumatism|March 31, 2007
Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohortDinesh Khanna, MyungShin Oh, Daniel E Furst, et al.
Clinical and Experimental Rheumatology|December 4, 2013
Recognition of pulmonary hypertension in the rheumatology community: lessons from a Quality Enhancement Research InitiativeD Khanna, Ma Tan, D E Furst, et al.
Lupus|June 24, 2022
Predictive model of risk and severity of enteritis in systemic lupus erythematosusWeijin Zhang, Guohai Huang, Jianqun Lin, et al.
Arthritis and Rheumatism|February 1, 1987
A controlled study of concurrent therapy with a nonacetylated salicylate and naproxen in rheumatoid arthritisD E Furst, K Blocka, S Cassell, et al.
The Journal of Rheumatology|February 11, 1998
Flare during drug withdrawal as a method to support efficacy in rheumatoid arthritis: amiprilose hydrochloride as an example in a double blind, randomized studyJ R Caldwell, D E Furst, A L Smith, et al.
Arthritis and Rheumatism|March 1, 1994
Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of RheumatologyJ M Kremer, G S Alarcón, R W Lightfoot, et al.
Pageof 76